Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3762454013 | Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3762455014 | Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Is a | Product containing sulfacetamide (medicinal product) | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Is a | Product containing sulfathiazole (medicinal product) | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Is a | Product containing sulfabenzamide (medicinal product) | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has active ingredient | Sulfabenzamide (substance) | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has active ingredient | Sulfacetamide (substance) | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has active ingredient | Sulfathiazole (substance) | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Is a | Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has manufactured dose form | Vaginal dose form (dose form) | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has manufactured dose form | Vaginal tablet | true | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Is a | Product containing sulfacetamide in vaginal dose form (medicinal product form) | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength numerator value | 144 | false | Inferred relationship | Some | 1 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has basis of strength substance (attribute) | Sulfacetamide sodium | true | Inferred relationship | Some | 1 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has precise active ingredient | Sulfacetamide sodium | true | Inferred relationship | Some | 1 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Is a | Sulfabenzamide and sulfacetamide and sulfathiazole only product in vaginal dose form | true | Inferred relationship | Some | ||
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength numerator value | 172 | false | Inferred relationship | Some | 3 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has precise active ingredient | Sulfathiazole (substance) | true | Inferred relationship | Some | 3 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has presentation strength numerator value | 184 | false | Inferred relationship | Some | 2 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has precise active ingredient | Sulfabenzamide (substance) | true | Inferred relationship | Some | 2 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has basis of strength substance (attribute) | Sulfabenzamide (substance) | true | Inferred relationship | Some | 2 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Has basis of strength substance (attribute) | Sulfathiazole (substance) | true | Inferred relationship | Some | 3 | |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets